Health tech sell-side mandates: who replies.

Health tech sell-side mandates are the easiest healthcare mandate an investment bank can take on, and our own data says so on two separate measures: how often owners reply, and how fast. Across 10,245 acquisition and exit emails to health tech owners, 50 were open to a conversation, 4.9 per 1,000 emails, more than five times the healthcare average. The same campaign produced its first positive reply on day one. We run sell-side mandate origination for boutique investment banks and M&A advisors, and this is the first page to put the health tech numbers on their own, rather than as one row inside a wider healthcare table.

No client is named here and no figure can be traced to one. The underlying data comes from our owner response rates by sector research and the healthcare cut published in healthcare sell-side mandates, with the speed figure cross-checked against the same campaign in our deal origination benchmarks.

What counts as a health tech sell-side mandate?

A health tech sell-side mandate represents a business that sells software, data or a digital service into healthcare, not a company that makes or distributes a physical medical product. Practice management software, remote patient monitoring, health data and analytics platforms, telehealth infrastructure and revenue-cycle software all sit inside this category. Medical device makers and distributors are a distinct buyer universe, covered separately in our medical device company acquisitions sourcing guide, and physician-owned practices are covered in medical practice deal sourcing firms. The distinction matters for sourcing because health tech owners are usually venture-backed founders rather than clinicians, which is most of the reason the reply data below looks the way it does.

What did we measure for health tech sell-side mandates?

We measured how health tech owners answered real acquisition and exit outreach between 19 June and 11 October 2026, as the health tech row of the twelve-sector owner response rates by sector study and the eight-sub-sector healthcare sell-side mandates cut.

• Emails. 10,245 sent to health tech owners, follow-ups included.
• Open to a conversation. A reply in which the owner said they were interested or asked for a call or meeting. Requests for more information are counted separately, so the figure is deliberately strict. 50 owners qualified.
• Human replies. 118, every reply except an out-of-office notice or a message that could not be classified.
• Emails per open owner. Emails sent divided by open owners, the number that turns a rate into a workload a bank can plan against.
• Do-not-contact share. The share of human replies that asked not to be contacted again, read as a rough measure of how tired a sector is of being approached.

How open are health tech owners to a sell-side conversation?

More open than any other sector we measure, on every column that matters to a bank building a pipeline.

Health tech owners were open to a conversation at 5.4 times the healthcare average and 4.1 times the twelve-sector average, and their do-not-contact share, 7%, was a little over a third of the healthcare figure. No other sector in either table combines a high reply rate with such a low refusal rate; med spas and elder and home care also answer close to the average, but with do-not-contact shares of 35% and 16% respectively.

Why do health tech owners reply fastest, not just most?

Because the same 10,245-email campaign that produced the reply rate above is also the one our deal origination benchmarks research tracks for speed, and its first positive reply came in on day one, the fastest result of any mandate we report there, tied with a facility services campaign covered in facility services sell-side mandates. Our read, consistent with the reply data, is that most health tech founders have already priced in an exit before a bank ever writes to them: many are venture-backed, many have investors who expect a liquidity event on a timeline, and a founder who has rehearsed the exit conversation internally answers a cold email about it faster than one who has not. That is different from a sector like medical practices, where the owner has often never had the conversation before and the email itself is the first prompt to think about it.

How many emails does one health tech mandate conversation take?

About 205, which is the cheapest conversation of any sector in our data. Put as a monthly plan:

Even 30 conversations a month, an aggressive target for a small team to properly qualify and follow up on, stays inside what a single well-built sending set-up can carry without straining deliverability. Compare that to industrial manufacturing sell-side mandates or home services sell-side outreach, where the same monthly target needs several times the volume. An open owner is a conversation, not a signed engagement letter; the bank still has to win the pitch, a distinction our sell-side vs buy-side origination piece covers from the buyer's side.

What makes a health tech sell-side pitch different from a physician-practice pitch?

The owner, the buyer universe and the proof the owner wants to see are all different. A health tech founder usually answers to a board and a cap table, so the first conversation is often as much about timing a process the investors will accept as it is about the founder's own appetite to sell. The pitch leads with recurring revenue and growth, not a multiple of trailing EBITDA, because that is how the business is actually valued. The buyer universe spans both strategic acquirers, health systems and incumbent health tech platforms buying a feature, and financial buyers running a roll-up or platform thesis, which is a wider field than a typical physician-practice sale draws. Diligence runs longer too, covering security, data handling and integration risk alongside the financials. None of that shows up in the reply-rate table above, but it is what an advisor has to be ready for once an open owner turns into an actual pitch.

How should an advisor pursue health tech sell-side mandates?

1. 1. Target founders directly, not a generic "leadership" title. Health tech's low do-not-contact share and high open share both point to a founder who is used to being approached about the business, so a specific, founder-addressed message outperforms a broad title-based list.
2. 2. Lead with the exit conversation the founder has probably already had internally. Reference growth, recurring revenue and timing rather than opening with a broad acquisition pitch; it matches how this owner already thinks about the business.
3. 3. Plan the volume against 205 emails per open owner, not against a generic healthcare assumption of 1,075. A health tech-only pipeline needs a fraction of the volume a mixed healthcare list does for the same number of conversations.
4. 4. Qualify board and investor involvement early. A venture-backed founder rarely controls the timeline alone, so the first call should surface who else needs to agree before a process can start.
5. 5. Route security and data-handling questions to the right person early. Longer technical diligence is normal in health tech; flagging it in the first conversation, rather than after a term sheet, keeps the process from stalling later.

Where does DealSource Systems fit?

DealSource Systems runs sell-side mandate origination for boutique investment banks and M&A advisors, including health tech specialists: owner-level lists, the written approach, sending infrastructure, reply handling and qualification, measured by the conversations it opens. It is priced at a flat $4,000 a month for a single defined thesis, with a 90-day minimum and no success fee, and the full pricing is published rather than quoted case by case, an arithmetic our sell-side mandate economics research runs against real engagement timelines. Merritt Healthcare Advisors, a healthcare investment bank running origination with us, reached 14 qualified founder conversations in its first three weeks and 133 within 90 days, published in full on our results page. The same question for other healthcare sub-sectors is answered in healthcare sell-side mandates and physical therapy sell-side mandates. A buyer rather than an advisor, building the acquisition side of a health tech thesis, can compare providers in health tech deal sourcing firms and deal sourcing firms for healthcare M&A advisors instead, and our wider playbook for the asset class is in deal origination for boutique investment banks.

Conclusion

Health tech sell-side mandates are the cheapest, fastest healthcare conversation in our own data: 4.9 open owners per 1,000 emails, 205 emails per open owner, and a first positive reply that has landed on day one. A bank that plans its health tech volume against that number, rather than a generic healthcare assumption, will reach the conversations it needs with a fraction of the list a harder sub-sector requires, and can spend the time it saves on winning the pitch instead of finding the owner.

Frequently asked questions